Novartis reported 4.81B in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1277M 119M
Bayer BAYN:GR 5.12B 72M
Biogen BIIB:US $ 427.9M 52.6M
Bristol Myers Squibb BMY:US $ 3609M 637M
Fresenius FRE:GR € 1669M 34M
Galapagos GLPG:NA 151.72M 10.15M
H. Lundbeck A/S LUN:DC 3.69B 19M
Hikma Pharmaceutical HIK:LN 226M 53M
Merck MRK:GR € 2107M 170M
Novartis NOVN:VX 4.81B 229M
Novartis NVS:US $ 4665M 146M
Orion ORNBV:FH 63.5M 18.6M
Recordati REC:IM 160.35M 15.29M
Regeneron Pharmaceuticals REGN:US $ 476M 66.9M